Details for New Drug Application (NDA): 019221
✉ Email this page to a colleague
The generic ingredient in VASERETIC is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.
Summary for 019221
Tradename: | VASERETIC |
Applicant: | Bausch |
Ingredient: | enalapril maleate; hydrochlorothiazide |
Patents: | 0 |
Pharmacology for NDA: 019221
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Physiological Effect | Decreased Blood Pressure Increased Diuresis |
Suppliers and Packaging for NDA: 019221
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221 | NDA | Bausch Health US, LLC | 0187-0146 | 0187-0146-01 | 100 TABLET in 1 BOTTLE (0187-0146-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG;25MG | ||||
Approval Date: | Oct 31, 1986 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG;12.5MG | ||||
Approval Date: | Jul 12, 1995 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 019221
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-003 | Jul 12, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-001 | Oct 31, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-001 | Oct 31, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-003 | Jul 12, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription